The importance of multifocal/multicentric tumor on the disease-free survival of breast cancer patients: Single center experience

MakaleYalnız künyeScopus SJRQ2
  • SDG 3 · Sağlık ve Kaliteli Yaşam

Özet

OBJECTIVES:: Multifocal/multicentric breast cancers have been comprehensively studied and their outcomes have been compared with unifocal tumors. We evaluated the impact of multifocality and multicentricity on the disease-free survival (DFS) and overall survival of breast cancer patients and tried to analyze the correlation between multifocality/multicentricity (M/M) and other prognostic factors. MATERIAL AND METHODS:: Between 1994 and 2009, we analyzed retrospectively 697 breast cancer patients. Multicentric and multifocal breast cancer were defined as the presence of 2 or more invasive tumor foci within the different quadrants of the same breast or within a same quadrant of the breast, respectively. M/M and other prognostic factors were evaluated using univariate and multivariate analyses. RESULTS:: Multifocal/multicentric tumors were seen in 107 (15.4%) of the 697 breast cancer patients. pT and pN stage were related with the presence of multifocal/multicentric tumors. As tumor size increased and the number of axillary lymph nodes metastasis increased, the incidence of M/M increased significantly (P=0.003 vs. P=0.02, respectively). Overall, the median DFS time of patients with multifocal/multicentric tumors was significantly worse than that of the unifocal tumors (55 vs. 137 mo, P<0.001). Multivariate analysis showed that the presence of M/M was the most important prognostic factor for DFS (P=0.001, hazard ratio (HR): 0.33; 95% confidence interval (CI), 0.18-0.58), as were pN stage and extracapsular extension of the tumor (P=0.01, HR: 1.74; 95% CI, 1.13-2.69) (P=0.03, HR: 1.9; 95% CI, 1.04-3.47, respectively). M/M were not also statistically significant prognostic factors in breast cancer for overall survival (P=0.06). CONCLUSIONS:: M/M imparts an unfavorable prognosis on the DFS of breast cancer patients in comparison to unifocal tumors and the presence of multifocal/multicentric tumors were associated with advanced pT and pN stages.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/gumushane/13120Resmi atıflarda kullanılan kalıcı adres
İndeks kayıtları
Kaydın indeks veri tabanlarındaki sayfası (aktarımda alınan kayıt numarasıyla). Erişim, indeksin kendi koşullarına bağlıdır.
Atıflar
Scopus
36
WoS
35
OpenAlex
41
Her kaynağın kendi saydığı toplam atıf; aktarım ve zenginleştirme sırasında alındı.
Tam Kayıt
AlanDeğerDil
dc.contributor.authorUstaalioglu, Basak Oven
dc.contributor.authorBilici, Ahmet
dc.contributor.authorKefeli, Umut
dc.contributor.authorŞeker, Mesut
dc.contributor.authorOncel, Mustafa
dc.contributor.authorGezen, Cem
dc.contributor.authorGumus, Mahmut
dc.contributor.authorDemirelli, Fuat
dc.date.accessioned2026-10-22T10:20:57.132815020Z
dc.date.available2026-10-22T10:20:57.132815020Z
dc.date.issued2012
dc.description.abstractOBJECTIVES:: Multifocal/multicentric breast cancers have been comprehensively studied and their outcomes have been compared with unifocal tumors. We evaluated the impact of multifocality and multicentricity on the disease-free survival (DFS) and overall survival of breast cancer patients and tried to analyze the correlation between multifocality/multicentricity (M/M) and other prognostic factors. MATERIAL AND METHODS:: Between 1994 and 2009, we analyzed retrospectively 697 breast cancer patients. Multicentric and multifocal breast cancer were defined as the presence of 2 or more invasive tumor foci within the different quadrants of the same breast or within a same quadrant of the breast, respectively. M/M and other prognostic factors were evaluated using univariate and multivariate analyses. RESULTS:: Multifocal/multicentric tumors were seen in 107 (15.4%) of the 697 breast cancer patients. pT and pN stage were related with the presence of multifocal/multicentric tumors. As tumor size increased and the number of axillary lymph nodes metastasis increased, the incidence of M/M increased significantly (P=0.003 vs. P=0.02, respectively). Overall, the median DFS time of patients with multifocal/multicentric tumors was significantly worse than that of the unifocal tumors (55 vs. 137 mo, P<0.001). Multivariate analysis showed that the presence of M/M was the most important prognostic factor for DFS (P=0.001, hazard ratio (HR): 0.33; 95% confidence interval (CI), 0.18-0.58), as were pN stage and extracapsular extension of the tumor (P=0.01, HR: 1.74; 95% CI, 1.13-2.69) (P=0.03, HR: 1.9; 95% CI, 1.04-3.47, respectively). M/M were not also statistically significant prognostic factors in breast cancer for overall survival (P=0.06). CONCLUSIONS:: M/M imparts an unfavorable prognosis on the DFS of breast cancer patients in comparison to unifocal tumors and the presence of multifocal/multicentric tumors were associated with advanced pT and pN stages.
dc.identifier.doi10.1097/coc.0b013e31822d9cd6
dc.identifier.eissn1537-453X
dc.identifier.endpage586
dc.identifier.issn1537-453X
dc.identifier.issue6
dc.identifier.pmid21926901
dc.identifier.scopus2-s2.0-84870255249
dc.identifier.startpage580
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/gumushane/13120
dc.identifier.volume35
dc.identifier.wosWOS:000311384000013
dc.language.isoen
dc.publisherLIPPINCOTT WILLIAMS & WILKINS
dc.relation.ispartofAmerican Journal of Clinical Oncology: Cancer Clinical Trials
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectbreast cancer
dc.subjectdisease-free survival
dc.subjectmulticentricity
dc.subjectmultifocality
dc.subject.classificationOncology
dc.subject.otherAdult
dc.subject.otherAged
dc.subject.otherAged, 80 and over
dc.subject.otherAxilla
dc.subject.otherBreast Neoplasms
dc.subject.otherCarcinoma, Ductal, Breast
dc.subject.otherCarcinoma, Lobular
dc.subject.otherDisease-Free Survival
dc.subject.otherFemale
dc.subject.otherHumans
dc.subject.otherKaplan-Meier Estimate
dc.subject.otherLymphatic Metastasis
dc.subject.otherMiddle Aged
dc.subject.otherMultivariate Analysis
dc.subject.otherNeoplasm Staging
dc.subject.otherNeoplasms, Multiple Primary
dc.subject.otherProportional Hazards Models
dc.subject.otherRetrospective Studies
dc.subject.otherSentinel Lymph Node Biopsy
dc.subject.otherTumor Burden
dc.subject.otherYoung Adult
dc.subject.otheranthracycline
dc.subject.otherantineoplastic agent
dc.subject.othertaxane derivative
dc.subject.otherarticle
dc.subject.otheraxillary lymph node
dc.subject.otherbreast cancer
dc.subject.otherbreast carcinoma
dc.subject.othercancer adjuvant therapy
dc.subject.othercancer chemotherapy
dc.subject.othercancer incidence
dc.subject.othercancer invasion
dc.subject.othercancer localization
dc.subject.othercancer patient
dc.subject.othercancer prognosis
dc.subject.othercancer radiotherapy
dc.subject.othercancer size
dc.subject.othercancer staging
dc.subject.othercancer surgery
dc.subject.othercancer survival
dc.subject.otherdisease free survival
dc.subject.otherdisease severity
dc.subject.otherhuman
dc.subject.otherintraductal carcinoma
dc.subject.otherlymph node dissection
dc.subject.otherlymph node metastasis
dc.subject.othermajor clinical study
dc.subject.othermastectomy
dc.subject.othermultiple cancer
dc.subject.otheroverall survival
dc.subject.otherpostmenopause
dc.subject.otherpremenopause
dc.subject.otherretrospective study
dc.titleThe importance of multifocal/multicentric tumor on the disease-free survival of breast cancer patients: Single center experience
dc.typeArticle
rdl.citation.openalex41
rdl.citation.scopus36
rdl.citation.wos35
rdl.oa.statusclosed
rdl.scopus.quartileQ2
rdl.sdgSDG03
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)